Literature DB >> 15557731

A second mitral valve replacement in a patient with hereditary hemorrhagic telangiectasia (Osler's disease).

Susumu Ishikawa1, Kiyohiro Oshima, Masahiro Aizaki, Toru Takahashi, Yutaka Hasegawa, Yasuo Morishita.   

Abstract

A 62-year-old female with Osler's disease was admitted to our hospital because of fever and cardiac failure. The patient had undergone a mitral valve replacement (MVR) using a Carpentier-Edwards prosthetic valve 14 years earlier. A bacterial examination of arterial blood identified Streptococcus mitis. No arteriovenous malformations were detected in visceral organs. The patient underwent MVR using the same prosthetic xenograft after conservative treatment and management of repetitive epistaxis and decayed teeth. Intra- and postoperative bleeding were typical of a mitral valve reoperation. This is the first reported experience, to the best of our knowledge, of a second MVR in a patient with Osler's disease.

Entities:  

Mesh:

Year:  2004        PMID: 15557731     DOI: 10.1536/jhj.45.885

Source DB:  PubMed          Journal:  Jpn Heart J        ISSN: 0021-4868


  3 in total

Review 1.  Infective endocarditis with Osler's nodule in a patient with Osler's disease: a case report and review of the literature.

Authors:  Genki Naruse; Takatomo Watanabe; Hiroyuki Okura
Journal:  J Med Case Rep       Date:  2022-05-29

2.  Redo cardiac surgery for active prosthetic valve endocarditis associated with hereditary hemorrhagic telangiectasia: report of a case.

Authors:  Yuki Nakamura; Fumiaki Shikata; Masahiro Ryugo; Toru Okamura; Takumi Yasugi; Hironori Izutani
Journal:  Surg Today       Date:  2014-03-20       Impact factor: 2.549

Review 3.  Probiotics and infective endocarditis in patients with hereditary hemorrhagic telangiectasia: a clinical case and a review of the literature.

Authors:  Evangelo Boumis; Alessandro Capone; Vincenzo Galati; Carolina Venditti; Nicola Petrosillo
Journal:  BMC Infect Dis       Date:  2018-02-01       Impact factor: 3.090

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.